Pharmaceutical giant Pfizer and biotech firm BioNTech have said their coronavirus vaccine was more than 90% effective in preventing Covid-19 among those without evidence of prior infection. The results are based on the first interim analysis of Phase 3 of the study, and evaluated 94 confirmed cases of Covid-19 in trial participants.